Impact of dabigatran on routine and specific coagulation assays in patients treated by dabigatran.

被引：0
|
作者：
Gemen, E. [1 ]
Kariman, A. [1 ]
Van Dijk, J. [1 ]
Van Eck, M. [1 ]
Pequeriaux, N. [1 ]
机构：
[1] Jeroen Bosch Hosp, Shertogenbosch, Netherlands
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：701 / 702
页数：2
相关论文
共 50 条
  • [31] Measurement of Dabigatran in Standardly Used Clinical Assays, Whole Blood Viscoelastic Coagulation, and Thrombin Generation Assays
    van Ryn, Joanne
    Grottke, Oliver
    Spronk, Henri
    CLINICS IN LABORATORY MEDICINE, 2014, 34 (03) : 479 - 501
  • [32] Whole blood coagulation assays ROTEM and T-TAS to monitor dabigatran treatment
    Taune, Viktor
    Wallen, Hakan
    Agren, Anna
    Gryfelt, Gunilla
    Sjovik, Carolina
    Wintler, Anna M.
    Malmstrom, Rickard E.
    Wikman, Agneta
    Skeppholm, Mika
    THROMBOSIS RESEARCH, 2017, 153 : 76 - 82
  • [33] Comparison of hemoclot to standard coagulation assays for monitoring the direct thrombin inhibitor (dabigatran) in pediatric patients: an in vitro study
    Mitchell, L. G.
    Dietrich, K.
    Stang, L.
    Etches, W.
    Qayyum, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 777 - 777
  • [34] ASSESSMENT OF IMPACT OF METABOLITES OF EDOXABAN AND DABIGATRAN ON FIBRIN AND THROMBIN GENERATION ASSAYS
    Evrard, Jonathan
    Siriez, Romain
    Maloteau, Vincent
    Dogne, Jean-Michel
    Douxfils, Jonathan
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 : 59 - 59
  • [35] Routine Coagulation Tests in Patients With Nonvalvular Atrial Fibrillation Under Dabigatran and Rivaroxaban Therapy: An Affordable and Reliable Strategy?
    Silva, Vanessa M.
    Scanavacca, Mauricio
    Darrieux, Francisco
    Cavalheiro, Cyrillo
    Strunz, Celia C.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
  • [36] Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
    Yvonne M. C. Henskens
    Anouk J. W. Gulpen
    René van Oerle
    Rick Wetzels
    Paul Verhezen
    Henri Spronk
    Simon Schalla
    Harry J. Crijns
    Hugo ten Cate
    Arina ten Cate-Hoek
    Thrombosis Journal, 16
  • [37] Detecting relevant rivaroxaban or dabigatran levels in clinical care by routine coagulation tests or thromboelastography in patients with atrial fibrillation
    Henskens, Y.
    van Oerle, R.
    Wetzels, R.
    Spronk, H.
    Schalla, S.
    Crijns, H.
    Cate, H. T.
    Cate-Hoek, A. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 902 - 903
  • [38] IS IT SAFE TO PERFORM JOINT PUNCTURES IN PATIENTS TREATED WITH DABIGATRAN?
    Guillen-Astete, C. A.
    Quinones-Torres, J. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 996 - 997
  • [39] Detecting clinically relevant rivaroxaban or dabigatran levels by routine coagulation tests or thromboelastography in a cohort of patients with atrial fibrillation
    Henskens, Yvonne M. C.
    Gulpen, Anouk J. W.
    van Oerle, Rene
    Wetzels, Rick
    Verhezen, Paul
    Spronk, Henri
    Schalla, Simon
    Crijns, Harry J.
    ten Cate, Hugo
    ten Cate-Hoek, Arina
    THROMBOSIS JOURNAL, 2018, 16
  • [40] Impact of Apixaban On a Large Panel of Routine or More Specific Coagulation Assays.
    Douxfils, Jonathan
    Mullier, Franois
    Chatelain, Christian
    Chatelain, Bernard
    Jean-Michel, Dogne
    BLOOD, 2012, 120 (21)
12345